Raytheon to support threat warnings for NORAD
Raytheon has been awarded a contract to support threat warnings and assessments for the North American Aerospace Defense Command (NORAD) Cheyenne Mountain Complex.
The $700 million indefinite-delivery/indefinite-quantity contract was announced on 1 April by Raytheon. Under this contract, the company will provide sustainment services and products supporting the integrated tactical warning/attack assessment system and other systems. The programme gives NORAD accurate and unambiguous warning and attack assessments of air, missile and space threats.
The contact work is expected to complete by 30 March 2020.
David Wajsgras, president of intelligence, information and services, Raytheon, said: 'Raytheon has deep expertise in sustainment and modification solutions that include sensor and software systems, radars, command and control, and range-engineering services.
'We look forward to working closely with the air force in this important area of national security.'
More from Land Warfare
-
Canada places $231 million order for 85 Rheinmetall HX trucks
Canada has become the 21st country to have ordered or operate HX trucks, of which more than 10,000 platforms have been sold in 4x4, 6x6 and 8x8 configurations worldwide.
-
Lockheed Martin to increase PAC-3 MSE production by 70%
The company manufactured 380 missiles in 2023 and plans to build 650 missiles per year from 2027.
-
Latvia enters talks to buy GDELS ASCOD IFV
The ASCOD is in service with, or has been ordered by, five countries. In the UK it forms the basis of the British Army’s Ajax and for the US it is the chassis for the M10 Booker.
-
Latvia orders more Patria 6x6 vehicles
The first Latvian-made Common Armoured Vehicle System (CAVS) 6x6 armoured personnel carrier was delivered to the Latvian National Armed Forces (NAF) in August, and more than 200 vehicles are expected to be delivered by 2029.
-
Canadian tech firm makes promise to increase precision and longevity of weapons
Supplied by Paradigm Shift, EPVD technology has undergone trials with the US and Canadian services.